CHAPERONE AI
Last Updated: June 23, 2026
CHAPERONE AI is an agentic AI-powered solution designed to improve outcomes for patients with complex cardiovascular-kidney-metabolic (CKM) conditions, where fragmented care and limited patient engagement drive high costs and poor outcomes. Leveraging advanced large language models, the platform delivers clinically validated, personalized guidance to patients and actionable insights to clinicians, supporting treatment decisions across diabetes, heart, and kidney disease. Built on Intel® Core™ Ultra and Intel® Xeon® processors and optimized with the OpenVINO™ toolkit and Intel® oneAPI Deep Neural Network Library (oneDNN), CHAPERONE AI enables efficient, scalable AI performance across edge, client, and cloud environments. Its ability to deliver accurate, empathetic, and real-time guidance supports continuous patient engagement while reducing clinical burden. By combining validated AI models with Intel-driven performance, CHAPERONE AI helps healthcare providers enhance care quality, improve outcomes, and manage costs at scale.
- Application Features
- Scalable AI Compute
- Optimized AI Models
- Efficient Deep Learning
- Flexible AI Deployment
Subscribe To Our Newsletter
Subscribe to the newsletter for the latest updates on materials posted on the Intel Industry Solution Builders program.
By submitting this form, you are confirming you are an adult 18 years or older and you agree to share your personal information with Intel to use for this business request. You also agree to subscribe to stay connected to the latest Intel technologies and industry trends by email and telephone. You may unsubscribe at any time. Intel’s websites and communications are subject to our Privacy Notice and Terms of Use.
By submitting this form, you are confirming you are an adult (18 years or older) and you agree to share your personal information with Intel to use for this business request. You also agree to subscribe to stay connected to the latest Intel technologies and industry trends by email. You may unsubscribe at any time. Intel’s websites and communications are subject to our Privacy Notice and Terms of Use.